CTIS.eu › Cities › France › Paris Cedex 13
Paris Cedex 13
France
312 total trials
145 recruiting
2022-502079-49-00
5
HIV-1 infection
2022-502099-22-00
5
HIV-1 Infection
2022-502126-40-00
5
HIV-1 infection
2023-503480-42-00
10
Hospital-acquired pneumonia
2023-506642-23-00
4
Active Pulmonary Sarcoidosis
2023-505469-95-00
10
Primary Sclerosing Cholangitis
2023-506599-28-01
4
Fulminant myocarditis
2024-513801-30-00
5
Recurrent Erysipelas in lower limbs
2024-513889-19-00
5
Multiple Myeloma
2024-513941-35-00
9
HIV Disease
2024-514659-13-00
5
Patients with severe forms of Recurrent Aphthous Stomatitis (RAS)
2024-515107-19-00
5
Patients (male or female) ≥18 years old with Detrusor overactivity (DO
2024-515714-40-00
4
Gout adult patients
2024-516215-24-00
4
TAkayasu ARteritiS
2024-516335-27-00
5
anti-MAG neuropathy
2024-516570-30-00
4
Relapsed/refractory T-cell Acute Lymphoblastic Leukemia
2024-517187-36-01
10
Dominantly Inherited Alzheimer’s Disease (DIAD)
2024-517310-15-00
3
Parkinson's Disease
2024-517621-54-00
5
High-risk non-muscle invasive bladder cancer (NMIBC) after transurethr
2024-518394-34-00
1
stroke
2024-519995-20-00
10
Maladie d' Alzheimer
2024-520089-70-00
5
Cutaneous lupus erythematosus
2025-520976-25-00
4
Relapsed/refractory multiple myeloma
2025-520995-24-00
5
Adult patients treated for haematological disorders, in whom chemother
Showing 1–24 of 312 trials